Basis: Current FMP quote-based enterprise value / four-quarter operating income. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBIT ratio is N/A as of 2026-10-06T22:12:10.596Z.
Calculation as of: 2026-10-06T22:12:10.596Z.
Quote observation: 2026-10-06T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 57b29b385eb1f41c31df3b51fd673e34c67ab99ff5acc6fa5376275c9290a164
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-02-26.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBIT RATIO
N/A
EV/EBIT RATIO AVG TTM
N/A
EV/EBIT RATIO AVG 3Y
N/A
EV/EBIT RATIO AVG 5Y
N/A
EV/EBIT RATIO AVG 10Y
N/A
EV/EBIT RATIO AVG 15Y
N/A
EV/EBIT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$63.78M
EV/EBIT Ratio
N/A
TTM Avg
31.50x
3Y Avg
31.50x
5Y Avg
31.50x
| NAME | MARKET CAP | EV/EBIT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Heron Therapeutics, Inc. (HRTX) | $62.78M | N/A | N/A | N/A | N/A |
| RenovoRx, Inc. (RNXT)vs › | $62.62M | N/A | N/A | N/A | N/A |
| InterCure Ltd. (INCR)vs › | $63.02M | N/A | 9.73x | 23.03x | 21.55x |
| Pliant Therapeutics, Inc. (PLRX)vs › | $63.78M | N/A | 31.50x | 31.50x | 31.50x |
| Alps Group Inc (ALPS)vs › | $64.18M | N/A | N/A | N/A | N/A |
| Fractyl Health, Inc. (GUTS)vs › | $60.42M | N/A | N/A | N/A | N/A |
| Oncolytics Biotech Inc. (ONCY)vs › | $60.02M | N/A | N/A | N/A | N/A |
| XBiotech Inc. (XBIT)vs › | $65.85M | N/A | N/A | N/A | N/A |
| Cingulate Inc. (CING)vs › | $65.86M | N/A | N/A | N/A | N/A |
| Gossamer Bio, Inc. (GOSS)vs › | $65.87M | N/A | N/A | N/A | N/A |
EV/EBIT = Enterprise Value / EBIT (TTM)
Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/EBIT RATIO |
|---|---|
| 2026-02-26 | 188.97x |
| 2026-02-25 | 176.17x |
| 2026-02-24 | 177.24x |
| 2026-02-23 | 187.91x |
| 2026-02-20 | 186.84x |
| 2026-02-19 | 187.91x |
| 2026-02-18 | 190.04x |
| 2026-02-17 | 187.91x |
| 2026-02-13 | 183.64x |
| 2026-02-12 | 183.64x |
| 2026-02-11 | 185.77x |
| 2026-02-10 | 196.44x |
| 2026-02-09 | 197.51x |
| 2026-02-06 | 195.37x |
| 2026-02-05 | 190.04x |
| 2026-02-04 | 201.77x |
| 2026-02-03 | 207.11x |
| 2026-02-02 | 208.17x |
| 2026-01-30 | 201.77x |
| 2026-01-29 | 203.91x |
| 2026-01-28 | 202.84x |
| 2026-01-27 | 210.31x |
| 2026-01-26 | 214.57x |
| 2026-01-23 | 212.44x |
| 2026-01-22 | 215.64x |
| 2026-01-21 | 216.71x |
| 2026-01-20 | 212.44x |
| 2026-01-16 | 219.91x |
| 2026-01-15 | 219.91x |
| 2026-01-14 | 219.91x |
| 2026-01-13 | 218.84x |
| 2026-01-12 | 219.91x |
| 2026-01-09 | 209.24x |
| 2026-01-08 | 196.44x |
| 2026-01-07 | 195.37x |
| 2026-01-06 | 191.11x |
| 2026-01-05 | 193.24x |
| 2026-01-02 | 195.37x |
| 2025-12-31 | 199.64x |
| 2025-12-30 | 204.97x |
| 2025-12-29 | 200.71x |
| 2025-12-26 | 197.51x |
| 2025-12-24 | 197.51x |
| 2025-12-23 | 197.51x |
| 2025-12-22 | 203.91x |
| 2025-12-19 | 199.64x |
| 2025-12-18 | 198.57x |
| 2025-12-17 | 196.44x |
| 2025-12-16 | 208.17x |
| 2025-12-15 | 210.31x |
| 2025-12-12 | 207.11x |
| 2025-12-11 | 207.11x |
| 2025-12-10 | 207.11x |
| 2025-12-09 | 202.84x |
| 2025-12-08 | 204.97x |
| 2025-12-05 | 200.71x |
| 2025-12-04 | 200.71x |
| 2025-12-03 | 196.44x |
| 2025-12-02 | 185.77x |
| 2025-12-01 | 183.64x |
| 2025-11-28 | 184.71x |
| 2025-11-26 | 180.44x |
| 2025-11-25 | 177.24x |
| 2025-11-24 | 181.51x |
| 2025-11-21 | 174.04x |
| 2025-11-20 | 174.04x |
| 2025-11-19 | 177.24x |
| 2025-11-18 | 180.44x |
| 2025-11-17 | 177.24x |
| 2025-11-14 | 178.31x |
| 2025-11-13 | 179.37x |
| 2025-11-12 | 179.37x |
| 2025-11-11 | 184.71x |
| 2025-11-10 | 179.37x |
| 2025-11-07 | 178.31x |
| 2025-11-06 | 178.31x |
| 2025-11-05 | 179.37x |
| 2025-11-04 | 272.57x |
| 2025-11-03 | 277.57x |
| 2025-10-31 | 275.07x |
| 2025-10-30 | 272.57x |
| 2025-10-29 | 276.32x |
| 2025-10-28 | 278.82x |
| 2025-10-27 | 277.57x |
| 2025-10-24 | 280.07x |
| 2025-10-23 | 278.82x |
| 2025-10-22 | 278.82x |
| 2025-10-21 | 292.58x |
| 2025-10-20 | 298.83x |
| 2025-10-17 | 291.33x |
| 2025-10-16 | 292.58x |
| 2025-10-15 | 298.83x |
| 2025-10-14 | 295.08x |
| 2025-10-13 | 292.58x |
| 2025-10-10 | 290.08x |
| 2025-10-09 | 293.83x |
| 2025-10-08 | 298.83x |
| 2025-10-07 | 295.08x |
| 2025-10-06 | 297.58x |
| 2025-10-03 | 295.08x |
| 2025-10-02 | 292.58x |
| 2025-10-01 | 286.32x |
| 2025-09-30 | 287.57x |
| 2025-09-29 | 288.83x |
| 2025-09-26 | 281.32x |
| 2025-09-25 | 282.57x |
| 2025-09-24 | 286.32x |
| 2025-09-23 | 285.07x |
| 2025-09-22 | 292.58x |
| 2025-09-19 | 283.82x |
| 2025-09-18 | 291.33x |
| 2025-09-17 | 281.32x |
| 2025-09-16 | 285.07x |
| 2025-09-15 | 285.07x |
| 2025-09-12 | 287.57x |
| 2025-09-11 | 290.08x |
| 2025-09-10 | 288.83x |
| 2025-09-09 | 292.58x |
| 2025-09-08 | 292.58x |
| 2025-09-05 | 293.83x |
| 2025-09-04 | 295.08x |
| 2025-09-03 | 296.33x |
| 2025-09-02 | 295.08x |
| 2025-08-29 | 298.83x |
| 2025-08-28 | 303.83x |
| 2025-08-27 | 300.08x |
| 2025-08-26 | 306.33x |
| 2025-08-25 | 302.58x |
| 2025-08-22 | 305.08x |
| 2025-08-21 | 295.08x |
| 2025-08-20 | 292.58x |
| 2025-08-19 | 291.33x |
| 2025-08-18 | 292.58x |
| 2025-08-15 | 296.33x |
| 2025-08-14 | 298.83x |
| 2025-08-13 | 305.08x |
| 2025-08-12 | 293.83x |
| 2025-08-11 | 290.08x |
